glp-1 receptor agonist use and risk of suicide death GLP-1s Like Ozempic May Be a New Treatment for Addiction New Data Shed Light On

How has CancerNetwork covered GLP-1 receptor agonists in oncology

Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation

The customer service praise is specific, detailed, and consistent

We confirmed the robustness of our findings for the composite outcomes, as complementary analyses using both a Fine-Gray model and a cause specific hazard model with time varying inverse probability-of-death censoring weights yielded consistent results on both relative and absolute scales (supplementary figures S5 and S7)

doi: 10.7748/ns.2025.e12464

Many patients find peace with chronic treatment when they reframe it as managing a chronic condition rather than failing at willpower